Modeling the T cell immune response: a fascinating challenge

Journal of Pharmacokinetics and Pharmacodynamics

Volumn 41, Issue 5, 2014, Pages 401-413

  Morel, Penelope A ^a   Faeder, James R ^a   Hawse, William F ^a   Miskov Zivanov, Natasa ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b Carnegie Mellon University ^*  (United States)

Author keywords

Immune regulation; Mathematical modeling; Signaling; T cell

Indexed keywords

MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 2; PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE 1; T LYMPHOCYTE RECEPTOR;

ADOPTIVE TRANSFER; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; GENETIC TRANSCRIPTION; HUMAN; IMMUNOLOGIST; LYMPHOCYTE DIFFERENTIATION; MOLECULAR DYNAMICS; NONHUMAN; REGULATORY T LYMPHOCYTE; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; BIOLOGICAL MODEL; COMPUTER SIMULATION; IMMUNOLOGY;

COMPUTER SIMULATION; HUMANS; MODELS, IMMUNOLOGICAL; T-LYMPHOCYTES;

EID: 84910006234     PISSN: 1567567X     EISSN: 15738744     Source Type: Journal    
DOI: 10.1007/s10928-014-9376-y     Document Type: Review

References (146)

1. Akira S, Takeda K (2004) Toll-like receptor signalling. Nat Rev Immunol 4:499–511
2. Takeda K, Kaisho T, Akira S (2003) Toll-like receptors. Annu Rev Immunol 21:335–376. doi:10.1146/annurev.immunol.21.120601.141126
3. Davis BK, Wen H, Ting JP-Y (2011) The inflammasome NLRs in immunity, inflammation, and associated diseases. Annu Rev Immunol 29:707–735 10.1146/annurev-immunol-031210-101405
4. Sancho D, Reis e Sousa C (2012) Signaling by myeloid C-type lectin receptors in immunity and homeostasis. Annu Rev Immunol 30:491–529 10.1146/annurev-immunol-031210-101352
5. Zelenay S, Reis e Sousa C (2013) Adaptive immunity after cell death. Trends Immunol 34:329–335. doi:10.1016/j.it.2013.03.005
6. McHeyzer-Williams LJ, McHeyzer-Williams MG (2005) Antigen-specific memory B cell development. Annu Rev Immunol 23:487–513. doi:10.1146/annurev.immunol.23.021704.115732
7. Mueller SN, Gebhardt T, Carbone FR, Heath WR (2013) Memory T cell subsets, migration patterns, and tissue residence. Annu Rev Immunol 31:137–161. doi:10.1146/annurev-immunol-032712-095954
8. Nath I, Vemuri N, Reddi AL, Jain S, Brooks P, Colston MJ, Misra RS, Ramesh V (2000) The effect of antigen presenting cells on the cytokine profiles of stable and reactional lepromatous leprosy patients. Immunol Lett 75:69–76
9. Berg DJ, Davidson N, xFc, hn R, xFc, ller W, Menon S, Holland G, Thompson-Snipes L, Leach MW, Rennick D (1996) Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses. J Clin Invest 98:1010–1020. doi:10.1172/jci118861
10. Hunter Christopher A, Kastelein R (2012) Interleukin-27: balancing protective and pathological immunity. Immunity 37:960–969. doi:10.1016/j.immuni.2012.11.003
11. Rouse BT, Suvas S (2004) Regulatory cells and infectious agents: détentes cordiale and contraire. J Immunol 173:2211–2215
12. Belkaid Y, Piccirillo CA, Mendez S, Shevach EM, Sacks DL (2002) CD4+ CD25 + regulatory T cells control Leishmania major persistence and immunity. Nature 420:502–507
13. Suzuki Y, Sher A, Yap G, Park D, Neyer LE, Liesenfeld O, Fort M, Kang H, Gufwoli E (2000) IL-10 is required for prevention of necrosis in the small intestine and mortality in both genetically resistant BALB/c and susceptible C57BL/6 mice following peroral infection with Toxoplasma gondii. J Immunol 164:5375–5382
14. Germain RN (2012) Maintaining system homeostasis: the third law of Newtonian immunology. Nat Immunol 13:902–906
15. Burke MA, Morel BF, Oriss TB, Bray J, McCarthy SA, Morel PA (1997) Modeling the proliferative response of T cells to IL-2 and IL-4. Cell Immunol 178:42–52
16. Morel BF, Burke MA, Kalagnanam JR, McCarthy SA, Tweardy DJ, Morel PA (1996) Making sense of the combined effect of interleukin-2 and interleukin-4 on lymphocytes using a mathematical model. Bull Mathemat Biol 58:569–594
17. Morel PA (1988) Mathematical modeling of immunological reactions. Frontiers Biosci 3:338–347
18. Morel PA, Ta’asan S, Morel BF, Kirschner DE, Flynn JL (2006) New insights into mathematical modeling of the immune system. Immunol Res 36:157–165. doi:10.1385/IR:36:1:157
19. Cantrell DA, Smith KA (1984) The interleukin-2 T-cell system: a new cell growth model. Science 224:1312–1316
20. Schorle H, Holtschke T, Hunig T, Schimpl A, Horak I (1991) Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting. Nature 352:621–624
21. Sadlack B, Merz H, Schorle H, Schimpl A, Feller AC, Horak I (1993) Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 75:253–261. doi:10.1016/0092-8674(93)80067-O
22. Malek TR (2003) The main function of IL-2 is to promote the development of T regulatory cells. J Leukocyte Biol 74:961–965. doi:10.1189/jlb.0603272
23. Furtado GC, Curotto de Lafaille MA, Kutchukhidze N, Lafaille JJ (2002) Interleukin 2 signaling is required for CD4(+) regulatory T cell function. J Exp Med 196:851–857
24. Tyson JJ, Novak B (2010) Functional motifs in biochemical reaction networks. Annu Rev Phys Chem 61:219–240. doi:10.1146/annurev.physchem.012809.103457
25. Zinkernagel RM, Doherty PC (1975) H-2 compatability requirement for T-cell-mediated lysis of target cells infected with lymphocytic choriomeningitis virus. Different cytotoxic T-cell specificities are associated with structures coded for in H-2K or H-2D. J Exp Med 141:1427–1436. doi:10.1084/jem.141.6.1427
26. Bjorkman PJ, Saper MA, Samraoui B, Bennett WS, Strominger JL, Wiley DC (1987) Structure of the human class I histocompatibility antigen, HLA-A2. Nature 329:506–512
27. Bjorkman PJ, Saper MA, Samraoui B, Bennett WS, Strominger JL, Wiley DC (1987) The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens. Nature 329:512–518
28. Ding Y-H, Smith KJ, Garboczi DN, Utz U, Biddison WE, Wiley DC (1998) Two human T cell receptors bind in a similar diagonal mode to the HLA-A2/Tax peptide complex using different TCR amino acids. Immunity 8:403–411. doi:10.1016/S1074-7613(00)80546-4
29. Speir JA, Garcia KC, Brunmark A, Degano M, Peterson PA, Teyton L, Wilson IA (1998) Structural basis of 2C TCR allorecognition of H-2Ld peptide complexes. Immunity 8:553–562. doi:10.1016/S1074-7613(00)80560-9
30. Garcia KC, Tallquist MD, Pease LR, Brunmark A, Scott CA, Degano M, Stura EA, Peterson PA, Wilson IA, Teyton L (1997) αβ T cell receptor interactions with syngeneic and allogeneic ligands: affinity measurements and crystallization. Proc Natl Acad Sci 94:13838–13843
31. Margulies DH, Plaksin D, Khilko SN, Jelonek MT (1996) Studying interactions involving the T-cell antigen receptor by surface plasmon resonance. Curr Opin Immunol 8:262–270
32. Hogquist KA, Baldwin TA, Jameson SC (2005) Central tolerance: learning self-control in the thymus. Nat Rev Immunol 5:772–782
33. Yates AJ (2014) Theories and quantification of thymic selection. Front Immunol 5:13. doi:10.3389/fimmu.2014.00013
34. Johnson PL, Yates AJ, Goronzy JJ, Antia R (2012) Peripheral selection rather than thymic involution explains sudden contraction in naive CD4 T-cell diversity with age. Proc Natl Acad Sci USA 109:21432–21437. doi:10.1073/pnas.1209283110
35. Johnson PL, Goronzy JJ, Antia R (2014) A population biological approach to understanding the maintenance and loss of the T cell repertoire during aging. Immunology. doi:10.1111/imm.12244
36. Van Den Berg HA, Rand DA, Burroughs NJ (2001) A reliable and safe T cell repertoire based on low-affinity T cell receptors. J Theor Biol 209:465–486. doi:10.1006/jtbi.2001.2281
37. Hapuarachchi T, Lewis J, Callard RE (2013) A mechanistic model for naive CD4 T cell homeostasis in healthy adults and children. Front Immunol 4:366. doi:10.3389/fimmu.2013.00366
38. Sawicka M, Stritesky GL, Reynolds J, Abourashchi N, Lythe G, Molina-Paris C, Hogquist KA (2014) From pre-DP, post-DP, SP4, and SP8 thymocyte cell counts to a dynamical model of cortical and medullary selection. Front Immunol 5:19. doi:10.3389/fimmu.2014.00019
39. Sinclair C, Bains I, Yates AJ, Seddon B (2013) Asymmetric thymocyte death underlies the CD4:CD8 T-cell ratio in the adaptive immune system. Proc Natl Acad Sci USA 110:E2905–E2914. doi:10.1073/pnas.1304859110
40. Mehr R, Globerson A, Perelson AS (1995) Modeling positive and negative selection and differentiation processes in the thymus. J Theor Biol 175:103–126. doi:10.1006/jtbi.1995.0124
41. Thomas-Vaslin V, Altes HK, de Boer RJ, Klatzmann D (2008) Comprehensive assessment and mathematical modeling of T cell population dynamics and homeostasis. J Immunol 180:2240–2250
42. Stritesky GL, Xing Y, Erickson JR, Kalekar LA, Wang X, Mueller DL, Jameson SC, Hogquist KA (2013) Murine thymic selection quantified using a unique method to capture deleted T cells. Proc Natl Acad Sci USA 110:4679–4684. doi:10.1073/pnas.1217532110
43. Bhakta NR, Oh DY, Lewis RS (2005) Calcium oscillations regulate thymocyte motility during positive selection in the three-dimensional thymic environment. Nat Immunol 6:143–151. http://www.nature.com/ni/journal/v6/n2/suppinfo/ni1161_S1.html
44. Liu X, Bosselut R (2004) Duration of TCR signaling controls CD4-CD8 lineage differentiation in vivo. Nat Immunol 5:280–288. doi:10.1038/ni1040
45. Palmer E, Naeher D (2009) Affinity threshold for thymic selection through a T-cell receptor-co-receptor zipper. Nat Rev Immunol 9:207–213
46. Mason D (1998) A very high level of crossreactivity is an essential feature of the T-cell receptor. Immunol Today 19:395–404
47. Zarnitsyna VI, Evavold BD, Schoettle LN, Blattman JN, Antia R (2013) Estimating the Diversity, Completeness, and Cross-Reactivity of the T Cell Repertoire. Front Immunol 4:485. doi:10.3389/fimmu.2013.00485
48. Hoerter JA, Brzostek J, Artyomov MN, Abel SM, Casas J, Rybakin V, Ampudia J, Lotz C, Connolly JM, Chakraborty AK, Gould KG, Gascoigne NR (2013) Coreceptor affinity for MHC defines peptide specificity requirements for TCR interaction with coagonist peptide-MHC. J Exp Med 210:1807–1821. doi:10.1084/jem.20122528
49. Yachi PP, Ampudia J, Gascoigne NRJ, Zal T (2005) Nonstimulatory peptides contribute to antigen-induced CD8-T cell receptor interaction at the immunological synapse. Nat Immunol 6:785–792. http://www.nature.com/ni/journal/v6/n8/suppinfo/ni1220_S1.html
50. Su LF, Davis MM (2013) Antiviral memory phenotype T cells in unexposed adults. Immunol Rev 255:95–109. doi:10.1111/imr.12095
51. Su LF, Kidd BA, Han A, Kotzin JJ, Davis MM (2013) Virus-specific CD4(+) memory-phenotype T cells are abundant in unexposed adults. Immunity 38:373–383. doi:10.1016/j.immuni.2012.10.021
52. Moon JJ, Chu HH, Pepper M, McSorley SJ, Jameson SC, Kedl Ross M, Jenkins MK (2007) Naive CD4+ T cell frequency varies for different epitopes and predicts repertoire diversity and response magnitude. Immunity 27:203–213. doi:10.1016/j.immuni.2007.07.007
53. Jenkins MK, Moon JJ (2012) The role of naive T cell precursor frequency and recruitment in dictating immune response magnitude. J Immunol 188:4135–4140. doi:10.4049/jimmunol.1102661
54. Six A, Mariotti-Ferrandiz ME, Chaara W, Magadan S, Pham HP, Lefranc MP, Mora T, Thomas-Vaslin V, Walczak AM, Boudinot P (2013) The past, present, and future of immune repertoire biology: the rise of next-generation repertoire analysis. Front Immunol 4:413. doi:10.3389/fimmu.2013.00413
55. Pannetier C, Cochet M, Darche S, Casrouge A, Zoller M, Kourilsky P (1993) The sizes of the CDR3 hypervariable regions of the murine T-cell receptor beta chains vary as a function of the recombined germ-line segments. Proc Natl Acad Sci USA 90:4319–4323
56. He M, Tomfohr JK, Devlin BH, Sarzotti M, Markert ML, Kepler TB (2005) SpA: web-accessible spectratype analysis: data management, statistical analysis and visualization. Bioinformatics 21:3697–3699. doi:10.1093/bioinformatics/bti600
57. Kepler TB, He M, Tomfohr JK, Devlin BH, Sarzotti M, Markert ML (2005) Statistical analysis of antigen receptor spectratype data. Bioinformatics 21:3394–3400. doi:10.1093/bioinformatics/bti539
58. Miqueu P, Guillet M, Degauque N, Dore JC, Soulillou JP, Brouard S (2007) Statistical analysis of CDR3 length distributions for the assessment of T and B cell repertoire biases. Mol Immunol 44:1057–1064. doi:10.1016/j.molimm.2006.06.026
59. Arstila TP, Casrouge A, Baron V, Even J, Kanellopoulos J, Kourilsky P (1999) A direct estimate of the human alphabeta T cell receptor diversity. Science 286:958–961
60. Turchaninova MA, Britanova OV, Bolotin DA, Shugay M, Putintseva EV, Staroverov DB, Sharonov G, Shcherbo D, Zvyagin IV, Mamedov IZ, Linnemann C, Schumacher TN, Chudakov DM (2013) Pairing of T-cell receptor chains via emulsion PCR. Eur J Immunol 43:2507–2515. doi:10.1002/eji.201343453
61. Michaeli M, Barak M, Hazanov L, Noga H, Mehr R (2013) Automated analysis of immunoglobulin genes from high-throughput sequencing: life without a template. J Clin Bioinform 3:15
62. Shapiro E, Biezuner T, Linnarsson S (2013) Single-cell sequencing-based technologies will revolutionize whole-organism science. Nat Rev Genet 14:618–630. doi:10.1038/nrg3542
63. Newell EW, Davis MM (2014) Beyond model antigens: high-dimensional methods for the analysis of antigen-specific T cells. Nat Biotechnol 32:149–157. doi:10.1038/nbt.2783
64. Wang C, Sanders CM, Yang Q, Schroeder HW, Wang E, Babrzadeh F, Gharizadeh B, Myers RM, Hudson JR, Davis RW, Han J (2010) High throughput sequencing reveals a complex pattern of dynamic interrelationships among human T cell subsets. Proc Natl Acad Sci 107:1518–1523. doi:10.1073/pnas.0913939107
65. Fohse L, Suffner J, Suhre K, Wahl B, Lindner C, Lee CW, Schmitz S, Haas JD, Lamprecht S, Koenecke C, Bleich A, Hammerling GJ, Malissen B, Suerbaum S, Forster R, Prinz I (2011) High TCR diversity ensures optimal function and homeostasis of Foxp3+ regulatory T cells. Eur J Immunol 41:3101–3113. doi:10.1002/eji.201141986
66. Wing JB, Sakaguchi S (2011) TCR diversity and Treg cells, sometimes more is more. Eur J Immunol 41:3097–3100. doi:10.1002/eji.201142115
67. Ferreira C, Singh Y, Furmanski AL, Wong FS, Garden OA, Dyson J (2009) Non-obese diabetic mice select a low-diversity repertoire of natural regulatory T cells. Proc Natl Acad Sci USA 106:8320–8325. doi:10.1073/pnas.0808493106
68. Caridade M, Oliveira VG, Agua-Doce A, Graca L, Ribeiro RM (2013) The fate of CD4+ T cells under tolerance-inducing stimulation: a modeling perspective. Immunol Cell Biol 91:652–660. doi:10.1038/icb.2013.63
69. Gowans JL, Knight EJ (1964) The route of re-circulation of lymphocytes in the rat. Proc R Soc Lond B 159:257–282
70. von Andrian UH, Mempel TR (2003) Homing and cellular traffic in lymph nodes. Nat Rev Immunol 3:867–878. doi:10.1038/nri1222
71. Kirberg J, Berns A, von Boehmer H (1997) Peripheral T cell survival requires continual ligation of the T cell receptor to major histocompatibility complex-encoded molecules. J Exp Med 186:1269–1275
72. Martin B, Becourt C, Bienvenu B, Lucas B (2006) Self-recognition is crucial for maintaining the peripheral CD4+ T-cell pool in a nonlymphopenic environment. Blood 108:270–277. doi:10.1182/blood-2006-01-0017
73. Viret C, Wong FS, Janeway CA Jr (1999) Designing and maintaining the mature TCR repertoire: the continuum of self-peptide:self-MHC complex recognition. Immunity 10:559–568
74. Sprent J (1973) Circulating T and B lymphocytes of the mouse. I. Migratory properties. Cell Immunol 7:10–39
75. Smith ME, Ford WL (1983) The recirculating lymphocyte pool of the rat: a systematic description of the migratory behaviour of recirculating lymphocytes. Immunology 49:83–94
76. Stekel DJ, Parker CE, Nowak MA (1997) A model of lymphocyte recirculation. Immunol Today 18:216–221
77. Miller MJ, Wei SH, Parker I, Cahalan MD (2002) Two-photon imaging of lymphocyte motility and antigen response in intact lymph node. Science 296:1869–1873. doi:10.1126/science.1070051
78. Sumen C, Mempel TR, Mazo IB, von Andrian UH (2004) Intravital microscopy: visualizing immunity in context. Immunity 21:315–329. doi:10.1016/j.immuni.2004.08.006
79. Mandl JN, Liou R, Klauschen F, Vrisekoop N, Monteiro JP, Yates AJ, Huang AY, Germain RN (2012) Quantification of lymph node transit times reveals differences in antigen surveillance strategies of naïve CD4+ and CD8+ T cells. Proc Natl Acad Sci 109:18036–18041. doi:10.1073/pnas.1211717109
80. Gottschalk RA, Hathorn MM, Beuneu H, Corse E, Dustin ML, Altan-Bonnet G, Allison JP (2012) Distinct influences of peptide-MHC quality and quantity on in vivo T-cell responses. Proc Natl Acad Sci USA 109:881–886. doi:10.1073/pnas.1119763109
81. Gong C, Linderman JJ, Kirschner D (2014) Harnessing the heterogeneity of T cell differentiation fate to fine-tune generation of effector and memory T cells. Front Immunol 5:57. doi:10.3389/fimmu.2014.00057
82. Lee M, Mandl JN, Germain RN, Yates AJ (2012) The race for the prize: T-cell trafficking strategies for optimal surveillance. Blood 120:1432–1438. doi:10.1182/blood-2012-04-424655
83. Gong C, Mattila JT, Miller M, Flynn JL, Linderman JJ, Kirschner D (2013) Predicting lymph node output efficiency using systems biology. J Theor Biol 335:169–184. doi:10.1016/j.jtbi.2013.06.016
84. Mirsky HP, Miller MJ, Linderman JJ, Kirschner DE (2011) Systems biology approaches for understanding cellular mechanisms of immunity in lymph nodes during infection. J Theor Biol 287:160–170. doi:10.1016/j.jtbi.2011.06.037
85. van der Merwe PA, Dushek O (2011) Mechanisms for T cell receptor triggering. Nat Rev Immunol 11:47–55. doi:10.1038/nri2887
86. Chakraborty AK, Das J (2010) Pairing computation with experimentation: a powerful coupling for understanding T cell signalling. Nat Rev Immunol 10:59–71. doi:10.1038/nri2688
87. Valitutti S, Muller S, Cella M, Padovan E, Lanzavecchia A (1995) Serial triggering of many T-cell receptors by a few peptide-MHC complexes. Nature 375:148–151. doi:10.1038/375148a0
88. Goldstein B, Faeder JR, Hlavacek WS (2004) Mathematical and computational models of immune-receptor signalling. Nat Rev Immunol 4:445–456
89. McKeithan TW (1995) Kinetic proofreading in T-cell receptor signal transduction. Proc Natl Acad Sci USA 92:5042–5046
90. Rabinowitz JD, Beeson C, Lyons DS, Davis MM, McConnell HM (1996) Kinetic discrimination in T-cell activation. Proc Natl Acad Sci USA 93:1401–1405
91. Sloan-Lancaster J, Allen PM (1996) Altered peptide ligand–induced partial T cell activation: molecular mechanisms and role in T cell biology. Annu Rev Immunol 14:1–27. doi:10.1146/annurev.immunol.14.1.1
92. Gascoigne NR, Zal T, Alam SM (2001) T-cell receptor binding kinetics in T-cell development and activation. Expert Rev Mol Med 2001:1–17. doi:10.1017/S1462399401002502
93. Tkach K, Altan-Bonnet G (2013) T cell responses to antigen: hasty proposals resolved through long engagements. Curr Opin Immunol 25:120–125. doi:10.1016/j.coi.2012.12.001
94. Altan-Bonnet G, Germain RN (2005) Modeling T cell antigen discrimination based on feedback control of digital ERK responses. PLoS Biol 3:e356. doi:10.1371/journal.pbio.0030356
95. Das J, Ho M, Zikherman J, Govern C, Yang M, Weiss A, Chakraborty AK, Roose JP (2009) Digital signaling and hysteresis characterize ras activation in lymphoid cells. Cell 136:337–351. doi:10.1016/j.cell.2008.11.051
96. Schmeitz C, Hernandez-Vargas EA, Fliegert R, Guse AH, Meyer-Hermann M (2013) A mathematical model of T lymphocyte calcium dynamics derived from single transmembrane protein properties. Front Immunol 4:277. doi:10.3389/fimmu.2013.00277
97. Monks CRF, Freiberg BA, Kupfer H, Sciaky N, Kupfer A (1998) Three-dimensional segregation of supramolecular activation clusters in T cells. Nature 395:82–86
98. Xie J, Tato CM, Davis MM (2013) How the immune system talks to itself: the varied role of synapses. Immunol Rev 251:65–79. doi:10.1111/imr.12017
99. Dustin ML, Depoil D (2011) New insights into the T cell synapse from single molecule techniques. Nat Rev Immunol 11:672–684. doi:10.1038/nri3066
100. Basak S, Behar M, Hoffmann A (2012) Lessons from mathematically modeling the NF-kappaB pathway. Immunol Rev 246:221–238. doi:10.1111/j.1600-065X.2011.01092.x
101. Behar M, Barken D, Werner SL, Hoffmann A (2013) The dynamics of signaling as a pharmacological target. Cell 155:448–461. doi:10.1016/j.cell.2013.09.018
102. Ramshaw IA, Eidinger D (1979) The in vitro induction of T cells which mediate delayed-type hypersensitivity toward horse red blood cells. Cell Immunol 42:42–47
103. Bretscher PA, Wei G, Menon JN, Bielefeldt-Ohmann H (1992) Establishment of stable, cell-mediated immunity that makes “susceptible” mice resistant to Leishmania major. Science 257:539–542
104. + T cell responses: the alternative approaches. Annu Rev Immunol 15:297–322
105. Hosken NA, Shibuya K, Heath AW, Murphy KM, O’Garra A (1995) The effect of antigen dose on CD4+ T helper cell phenotype development in a T cell receptor-alpha beta-transgenic model. J Exp Med 182:1579–1584
106. Zhu J, Yamane H, Paul WE (2010) Differentiation of effector CD4 T cell populations (*). Annu Rev Immunol 28:445–489. doi:10.1146/annurev-immunol-030409-101212
107. Hong T, Xing J, Li L, Tyson JJ (2011) A mathematical model for the reciprocal differentiation of T helper 17 cells and induced regulatory T cells. PLoS Comput Biol 7:e1002122. doi:10.1371/journal.pcbi.1002122
108. Mendoza L (2006) A network model for the control of the differentiation process in Th cells. Biosystems 84:101–114. doi:10.1016/j.biosystems.2005.10.004
109. Naldi A, Carneiro J, Chaouiya C, Thieffry D (2010) Diversity and plasticity of Th cell types predicted from regulatory network modelling. PLoS Comput Biol 6:e1000912. doi:10.1371/journal.pcbi.1000912
110. van den Ham HJ, de Boer RJ (2012) Cell division curtails helper phenotype plasticity and expedites helper T-cell differentiation. Immunol Cell Biol 90:860–868. doi:10.1038/icb.2012.23
111. Turner MS, Kane LP, Morel PA (2009) Dominant role of antigen dose in CD4+ Foxp3+ regulatory T cell induction and expansion. J Immunol 183:4895–4903. doi:10.4049/jimmunol.0901459
112. Daniel C, Weigmann B, Bronson R, von Boehmer H (2011) Prevention of type 1 diabetes in mice by tolerogenic vaccination with a strong agonist insulin mimetope. J Exp Med 208:1501–1510. doi:10.1084/jem.20110574
113. Gottschalk RA, Corse E, Allison JP (2010) TCR ligand density and affinity determine peripheral induction of Foxp3 in vivo. J Exp Med 207:1701–1711. doi:10.1084/jem.20091999
114. Kretschmer K, Apostolou I, Hawiger D, Khazaie K, Nussenzweig MC, von Boehmer H (2005) Inducing and expanding regulatory T cell populations by foreign antigen. Nat Immunol 6:1219–1227
115. Haxhinasto S, Mathis D, Benoist C (2008) The AKT-mTOR axis regulates de novo differentiation of CD4+ Foxp3+ cells. J Exp Med 205:565–574
116. Sauer S, Bruno L, Hertweck A, Finlay D, Leleu M, Spivakov M, Knight ZA, Cobb BS, Cantrell D, O’Connor E, Shokat KM, Fisher AG, Merkenschlager M (2008) T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR. Proc Natl Acad Sci USA 105:7797–7802
117. Turner MS, Isse K, Turnquist HR, Morel PA (2014) Low TCR signal strength induces combined expansion of Th2 and regulatory T cell populations that protect mice from the development of type 1 diabetes. Diabetologia 57(7):1428–1436
118. Miskov-Zivanov N, Turner MS, Kane LP, Morel PA, Faeder JR (2013) The duration of T cell stimulation is a critical determinant of cell fate and plasticity. Sci Signal 6:ra97. doi:10.1126/scisignal.2004217
119. Wang RS, Saadatpour A, Albert R (2012) Boolean modeling in systems biology: an overview of methodology and applications. Phys Biol 9:055001. doi:10.1088/1478-3975/9/5/055001
120. Feinerman O, Veiga J, Dorfman JR, Germain RN, Altan-Bonnet G (2008) Variability and robustness in T cell activation from regulated heterogeneity in protein levels. Science 321:1081–1084. doi:10.1126/science.1158013
121. Liston A, Gray DH (2014) Homeostatic control of regulatory T cell diversity. Nat Rev Immunol 14:154–165. doi:10.1038/nri3605
122. Lan RY, Selmi C, Gershwin ME (2008) The regulatory, inflammatory, and T cell programming roles of interleukin-2 (IL-2). J Autoimmun 31:7–12. doi:10.1016/j.jaut.2008.03.002
123. Feinerman O, Jentsch G, Tkach KE, Coward JW, Hathorn MM, Sneddon MW, Emonet T, Smith KA, Altan-Bonnet G (2010) Single-cell quantification of IL-2 response by effector and regulatory T cells reveals critical plasticity in immune response. Mol Syst Biol 6:437. doi:10.1038/msb.2010.90
124. Tang Q, Adams JY, Penaranda C, Melli K, Piaggio E, Sgouroudis E, Piccirillo CA, Salomon BL, Bluestone JA (2008) Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction. Immunity 28:687–697. doi:10.1016/j.immuni.2008.03.016
125. Dendrou CA, Wicker LS (2008) The IL-2/CD25 pathway determines susceptibility to T1D in humans and NOD mice. J Clin Immunol 28:685–696. doi:10.1007/s10875-008-9237-9
126. Boyman O, Surh CD, Sprent J (2006) Potential use of IL-2/anti-IL-2 antibody immune complexes for the treatment of cancer and autoimmune disease. Expert opinion on biological therapy 6:1323–1331. doi:10.1517/14712598.6.12.1323
127. Garcia-Martinez K, Leon K (2010) Modeling the role of IL-2 in the interplay between CD4+ helper and regulatory T cells: assessing general dynamical properties. J Theor Biol 262:720–732. doi:10.1016/j.jtbi.2009.10.025 S0022-5193(09)00506-2 [pii]
128. Leon K, Garcia-Martinez K, Carmenate T (2013) Mathematical models of the impact of IL2 modulation therapies on T Cell dynamics. Front Immunol 4:439. doi:10.3389/fimmu.2013.00439
129. Butler TC, Kardar M, Chakraborty AK (2013) Quorum sensing allows T cells to discriminate between self and nonself. Proc Natl Acad Sci USA 110:11833–11838. doi:10.1073/pnas.1222467110
130. Mamchak AA, Manenkova Y, Leconet W, Zheng Y, Chan JR, Stokes CL, Shoda LK, von Herrath M, Bresson D (2012) Preexisting autoantibodies predict efficacy of oral insulin to cure autoimmune diabetes in combination with anti-CD3. Diabetes 61:1490–1499. doi:10.2337/db11-1304
131. Bresson D, Togher L, Rodrigo E, Chen Y, Bluestone JA, Herold KC, von Herrath M (2006) Anti-CD3 and nasal proinsulin combination therapy enhances remission from recent-onset autoimmune diabetes by inducing Tregs. J Clin Investig 116:1371–1381. doi:10.1172/jci27191
132. Chatenoud L, Thervet E, Primo J, Bach JF (1994) Anti-CD3 antibody induces long term remission of overt autoimmunity in nonobese diabetic mice. Proc Natl Acad Sci USA 91:123–127
133. Fernandes P, Jain P, Moita C (2012) Training experimental biologists in bioinformatics. Advances in bioinformatics 2012:672749. doi:10.1155/2012/672749
134. Loman N, Watson M (2013) So you want to be a computational biologist? Nat Biotechnol 31:996–998. doi:10.1038/nbt.2740
135. Faeder JR, Hlavacek WS, Reischl I, Blinov ML, Metzger H, Redondo A, Wofsy C, Goldstein B (2003) Investigation of early events in Fc epsilon RI-mediated signaling using a detailed mathematical model. J Immunol 170:3769–3781
136. Lipniacki T, Hat B, Faeder JR, Hlavacek WS (2008) Stochastic effects and bistability in T cell receptor signaling. J Theor Biol 254:110–122. doi:10.1016/j.jtbi.2008.05.001
137. Chylek LA, Harris LA, Tung CS, Faeder JR, Lopez CF, Hlavacek WS (2013) Rule-based modeling: a computational approach for studying biomolecular site dynamics in cell signaling systems. Wiley Interdiscip Rev Syst Biol Med. doi:10.1002/wsbm.1245
138. Saez-Rodriguez J, Simeoni L, Lindquist JA, Hemenway R, Bommhardt U, Arndt B, Haus U-U, Weismantel R, Gilles ED, Klamt S, Schraven B (2007) A logical model provides insights into T cell receptor signaling. PLoS Comput Biol 3:e163. doi:10.1371/journal.pcbi.0030163
139. Klamt S, Saez-Rodriguez J, Lindquist JA, Simeoni L, Gilles ED (2006) A methodology for the structural and functional analysis of signaling and regulatory networks. BMC Bioinform 7:56. doi:10.1186/1471-2105-7-56
140. Narang V, Decraene J, Wong SY, Aiswarya BS, Wasem AR, Leong SR, Gouaillard A (2012) Systems immunology: a survey of modeling formalisms, applications and simulation tools. Immunol Res 53:251–265. doi:10.1007/s12026-012-8305-7
141. Germain RN, Meier-Schellersheim M, Nita-Lazar A, Fraser IDC (2011) Systems biology in immunology: a computational modeling perspective. Annu Rev Immunol 29:527–585. doi:10.1146/annurev-immunol-030409-101317
142. Kirschner DE, Chang ST, Riggs TW, Perry N, Linderman JJ (2007) Toward a multiscale model of antigen presentation in immunity. Immunol Rev 216:93–118. doi:10.1111/j.1600-065X.2007.00490.x
143. Sadot A, Sarbu S, Kesseli J, Amir-Kroll H, Zhang W, Nykter M, Shmulevich I (2013) Information-theoretic analysis of the dynamics of an executable biological model. PLoS ONE 8:e59303. doi:10.1371/journal.pone.0059303
144. Faeder JR, Blinov ML, Hlavacek WS (2009) Rule-based modeling of biochemical systems with BioNetGen. Methods Mol Biol 500:113–167. doi:10.1007/978-1-59745-525-1_5
145. Zhang F, Angermann BR, Meier-Schellersheim M (2013) The simmune modeler visual interface for creating signaling networks based on bi-molecular interactions. Bioinformatics 29:1229–1230. doi:10.1093/bioinformatics/btt134
146. Lizée G, Overwijk WW, Radvanyi L, Gao J, Sharma P, Hwu P (2013) Harnessing the power of the immune system to target cancer. Annu Rev Med 64:71–90. doi:10.1146/annurev-med-112311-083918